Skip to content

Candidate Predictors of Changes in Heart function

Candidate Predictors of Changes in Heart function - MINERVA substudy

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31564
Enrollment
10
Registered
2008-02-12
Start date
2008-05-29
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

Patients have an indication for a dual chamber pacemaker and will receive an Enrhythm device (irrespective of participation in the substudy). There will be no additional interventions in the substud

Sponsors

Medtronic Trading NL BV
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) Class I/II indication for dual chamber pacemaker 2) Previous implant of an Enrhythm dual chamber pacemaker since max 2 weeks 3) Documented history of atrial arrhythmias in last 12 months 4) Randomised assignment to control group in the Minerva main study

Exclusion criteria

Exclusion criteria: - Younger than 18 years - History of permanent atrial fibrillation - Candidates for implantable defibrillator (ICD) or Cardiac Resynchronization Therapy (CRT) - Permanent AV block or AV-node ablation - Anticipated major cardiac surgery within the course of the study - Random assignment to DDDRP group or MVP group

Design outcomes

Primary

MeasureTime frame
Heart function as measured with sensitive tissue/doppler echocardiography (including Ejection fraction, right-left ventricular synchrony) and blood values (BNP).

Secondary

MeasureTime frame
NYHA class (severity of symptoms)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)